Skip to content

BIESEMANS-CORNILLE

Active
Private limited companyfounded 201214 years activeGeneraal Lemanlaan 78, 8310 Brugge, BelgiumKBO/BCE: BE 0849.205.603
Summary

BIESEMANS-CORNILLE has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €218,722 and a net result of -€15,911. Equity is growing by ~70.7% per year across the filed fiscal years. Its solvency ranks better than 26% of 12,411 sector peers (NACE 47, fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€1.4mtotal assets 2025
Staff
0.7 FTE
Equity
€218,722
Loss
-€15,911
Turnover not published (abridged schema)
Financial health
83 Excellent Checked score 2025
Bankruptcy probability, 12 months
0.4%
Structure
Accounts filed 24 days late0 of 2 deeds read
Why 83- Equity €218,722 (15.5% of total assets)- Sector Retail trade (NACE 47)+ Size: 0.7 FTE, total assets €1.4m+ Figures for FY 2025 (filed 24-08-2026)Show the evidence

Checked score

Score 2025
83 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 41% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Average
Solvency 40-8
equity 15.5% of total assets
Liquidity 51-1
short-term debt 27.8% · cash 9.6%
Profitability 67-7
return on assets -1.1%
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%

About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,155 companies)
Last 24 months 11-2024: 0.3% 12-2024: 0.3%● unchanged vs 11-2024 01-2025: 0.3%● unchanged vs 12-2024 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.4%▲ +0.1 percentage points vs 05-2025 07-2025: 0.6%▲ +0.2 percentage points vs 06-2025 08-2025: 0.2%▼ -0.4 percentage points vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026lowest value 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.3%▲ +0.1 percentage points vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.4%▲ +0.1 percentage points vs 06-2026 08-2026: 0.8%▲ +0.4 percentage points vs 07-2026highest value 09-2026: 0.4%▼ -0.4 percentage points vs 08-2026 10-2026: 0.4%● unchanged vs 09-2026
Credit up to €18,000 at 30 days acceptable
Liquidity short (current ratio 1.0 against 1.12 in 2024; short-term debt: 27.8% and cash: 9.6% of total assets), and 84.5% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 32% on solvency, 55% on liquidity, 47% on profitability and 29% on growth.

The bankruptcy probability was computed on 06-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals.
−lowers risk+raises risk○neutral
lowers risk · Size: 0.7 FTE, total assets €1.4m
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
raises risk · Equity €218,722 (15.5% of total assets)
NBB · annual accounts
raises risk · Sector Retail trade (NACE 47)
KBO
lowers risk · Figures for FY 2025 (filed 24-08-2026)
NBB · annual accounts
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-08-2026, 24 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
24 days late
2024
17 days early
2023
30 days late
2022
13 days early
2021
31 days late
2020
15 days early
2019
31 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 10 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 24 August (4 of the last 5 filed years within 37 days of that day).
Companies Code · seven months
Position in the running window
07-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · abbreviated…
  2. Weakest financial yearnet -€15,911
  3. Annual accounts filedfiscal year 2024 · abbreviated…

Key points

  • Caution: From profit to loss in 2025after €43,774 in 2024 -€15,911 View
  • Caution: Among the weakest 15% on net resultsector median €28,351 · 12,399 companies -€15,911 View
  • Total assets 20256 fiscal years filed €1.4m View

By topic

Financials

Fiscal year
2025
Total assets
€1.4m
Loss
-€15,911
Solvency
15.5%
Total assets▲ 37.7%
Net result
20182025
Go to Financials

Timeline

Events
14
Since
2017
Next accounts
by 31-07-2027
  1. 31-12-2024Equity above €200,000
  2. 30-08-2024Annual accounts filed
  3. 31-12-2023Highest result since 2018
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
02-10-2012
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.